Rezolute RZLT
NASDAQ RZLT
$4.57 +0.03 (+0.77%)
As of: Sep 4, 2026 · 1:33 PM EDT

Rezolute (RZLT) Operating Income (2012 - 2026)

Rezolute (RZLT) posted Operating Income of -$17.4 million for Q1 2026, up 28.3% sequentially from -$24.2 million in Q4 2025, and up 13.27% YoY from -$15.3 million in Q1 2025.

Analysis

Rezolute (RZLT) Operating Income (2012 - 2026) Analysis & Trends

Rezolute has reported Operating Income for 15 years, with the latest figure at -$17.4 million in Q1 2026.

  • Quarterly Operating Income rose 13.27% year-over-year to -$17.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$87.3 million (down 13.1% YoY) and the FY2025 annual result came in at -$79.9 million, down 13.45% from the prior year.
  • Operating Income advanced to -$17.4 million in Q1 2026 per RZLT's latest filing, from -$24.2 million in the prior quarter.
  • Over five years, Operating Income peaked at -$10.2 million in Q3 2022 and troughed at -$25.8 million in Q2 2025.
  • A 5-year average of -$17.0 million and a median of -$16.9 million in 2024 frame the typical range for Operating Income.
  • The sharpest annual moves came in 2022 and 2026: Operating Income plunged 96.13% in 2022, then climbed 13.27% in 2026.
  • Over 5 years, Operating Income stood at -$14.4 million in 2022, then declined by 5.57% to -$15.2 million in 2023, then dropped by 12.41% to -$17.1 million in 2024, then sank by 41.81% to -$24.2 million in 2025, then increased by 28.3% to -$17.4 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered -$17.4 million, -$24.2 million, and -$19.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 493.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -505.13 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 133.12 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -1.55 Mn
10 Rezolute 475.98 Mn 475.98 Mn - -17.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.37 Mn
Dec 31, 2025 -24.22 Mn
Sep 30, 2025 -19.82 Mn
Jun 30, 2025 -25.85 Mn
Mar 31, 2025 -20.02 Mn
Dec 31, 2024 -17.08 Mn
Sep 30, 2024 -16.94 Mn
Jun 30, 2024 -23.10 Mn
Mar 31, 2024 -16.21 Mn
Dec 31, 2023 -15.19 Mn
Sep 30, 2023 -15.91 Mn
Jun 30, 2023 -14.24 Mn
Mar 31, 2023 -17.14 Mn
Dec 31, 2022 -14.39 Mn
Sep 30, 2022 -10.22 Mn
Jun 30, 2022 -11.30 Mn
Mar 31, 2022 -10.75 Mn
Dec 31, 2021 -12.15 Mn
Sep 30, 2021 -7.64 Mn
Jun 30, 2021 -6.64 Mn